Anticytokine treatment prevents the increase in the activity of ATP-ubiquitin- and Ca2+-dependent proteolytic systems in the muscle of tumour-bearing rats

被引:68
作者
Costelli, P
Bossola, M
Muscaritoli, M
Grieco, G
Bonelli, G
Bellantone, R
Doglietto, GB
Baccino, FM
Fanelli, FR
机构
[1] Univ Turin, Dipartimento Med & Oncol Sperimentale, I-10125 Turin, Italy
[2] Univ Cattolica, Ist Clin Chirurg, Rome, Italy
[3] Univ Roma La Sapienza, Dipartimento Clin Med, Rome, Italy
[4] Ctr CNR CIOS, Turin, Italy
关键词
cancer cachexia; protein turnover; pentoxifylline; suramin; TNF-alpha; hypercatabolism;
D O I
10.1006/cyto.2002.1036
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The ascites hepatoma Yoshida AH-130 induces loss of body weight and tissue waste. Tumour necrosis factor alpha (TNF-alpha) plays a pivotal role in the pathogenesis of muscle wasting in this model system, but other cytokines, such as interleukin-6, may be involved. In order to verify whether a combined anticytokine treatment may synergistically counteract muscle protein degradation, tumour bearing rats were treated with pentoxyfilline (PTX, an inhibitor of TNF-alpha synthesis), or with suramin (SUR, an antiprotozoal drug blocking the peripheral action of several cytokines including IL-6 and TNF-alpha), or both the drugs, and the effects on muscle proteolytic systems were assessed. Muscle protein loss in the AH-130-bearing rats was associated with increased activity of both the ATP-ubiquitin- and the calpain-dependent proteolytic pathways (246% and 230% of controls, respectively). Both PTX and SUR, either alone or in combination, prevented the depletion of muscle mass and significantly reduced the activity of muscle proteolytic systems. In particular, treatment with SUR, either alone or with PTX, induced a decrease in enzymatic activities to values similar to those of controls. The results obtained in the present paper demonstrate that: (i) muscle depletion in this model is indeed associated with increased proteasome- and calpain-dependent proteolysis, as previously suggested by increased mRNA expression of molecules pertaining to both pathways; (ii) anticytokine treatments effectively reduce muscle protein loss by down-regulating the activity of at least two major proteolitic systems; (iii) SUR is more effective than PTX in reducing the activity of proteolytic systems, possibly because of its multiple anticytokine action. (C) 2002 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:1 / 5
页数:5
相关论文
共 33 条
[1]  
ALZANI R, 1993, J BIOL CHEM, V268, P12526
[2]  
Argilés JM, 1999, INT J ONCOL, V14, P479
[3]   ACTIVATION OF THE ATP-UBIQUITIN-PROTEASOME PATHWAY IN SKELETAL-MUSCLE OF CACHECTIC RATS BEARING A HEPATOMA [J].
BARACOS, VE ;
DEVIVO, C ;
HOYLE, DHR ;
GOLDBERG, AL .
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 1995, 268 (05) :E996-E1006
[4]   Proteasome activities decrease during dexamethasone-induced apoptosis of thymocytes [J].
Beyette, J ;
Mason, GGF ;
Murray, RZ ;
Cohen, GM ;
Rivett, AJ .
BIOCHEMICAL JOURNAL, 1998, 332 :315-320
[5]   Increased muscle ubiquitin mRNA levels in gastric cancer patients [J].
Bossola, M ;
Muscaritoli, M ;
Costelli, P ;
Bellantone, R ;
Pacelli, F ;
Busquets, S ;
Argilès, J ;
Lopez-Soriano, FJ ;
Civello, IM ;
Baccino, FM ;
Fanelli, FR ;
Doglietto, GB .
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY, 2001, 280 (05) :R1518-R1523
[6]   Serum tumour necrosis factor-α levels in cancer patients are discontinuous and correlate with weight loss [J].
Bossola, M ;
Muscaritoli, M ;
Bellantone, R ;
Pacelli, F ;
Cascino, A ;
Sgadari, A ;
Battaglia, F ;
Piccioni, E ;
Scambia, G ;
Doglietto, GB ;
Fanelli, FR .
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2000, 30 (12) :1107-1112
[7]   PENTOXIFYLLINE DECREASES BODY-WEIGHT LOSS AND MUSCLE PROTEIN WASTING CHARACTERISTICS OF SEPSIS [J].
BREUILLE, D ;
FARGE, MC ;
ROSE, F ;
ARNAL, M ;
ATTAIX, D ;
OBLED, C .
AMERICAN JOURNAL OF PHYSIOLOGY, 1993, 265 (04) :E660-E666
[8]   ANTITUMOR NECROSIS FACTOR-ALPHA TREATMENT INTERFERES WITH CHANGES IN LIPID-METABOLISM IN A TUMOR CACHEXIA MODAL [J].
CARBO, N ;
COSTELLI, P ;
TESSITORE, L ;
BAGBY, GJ ;
LOPEZSORIANO, FJ ;
BACCINO, FM ;
ARGILES, JM .
CLINICAL SCIENCE, 1994, 87 (03) :349-355
[9]   Manipulation of the ubiquitin-proteasome pathway in cachexia:: pentoxifylline suppresses the activation of 20S and 26S proteasomes in muscles from tumor-bearing rats [J].
Combaret, L ;
Rallière, C ;
Taillandier, D ;
Tanaka, K ;
Attaix, D .
MOLECULAR BIOLOGY REPORTS, 1999, 26 (1-2) :95-101
[10]  
Costelli P, 2000, Curr Opin Clin Nutr Metab Care, V3, P177, DOI 10.1097/00075197-200005000-00003